Scarica l'app Stockscreener
1.07
1.83%
-0.02
Pre-mercato:
1.07
Precedente Chiudi:
$1.09
Aprire:
$1.1
Volume 24 ore:
13.61M
Relative Volume:
0.48
Capitalizzazione di mercato:
$404.31M
Reddito:
$199.32M
Utile/perdita netta:
$-272.74M
Rapporto P/E:
-0.5489
EPS:
-1.9494
Flusso di cassa netto:
$-63.86M
1 W Prestazione:
-7.76%
1M Prestazione:
-13.01%
6M Prestazione:
-32.28%
1 anno Prestazione:
-40.88%
Intervallo 1D:
$1.05
$1.11
Intervallo di 1 settimana:
$1.05
$1.1587
Portata 52W:
$0.77
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Nome
Canopy Growth Corporation
Settore
Telefono
855-558-9333
Indirizzo
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.07 | 411.87M | 199.32M | -272.74M | -63.86M | -1.9494 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-10 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2023-04-04 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2022-11-02 | Iniziato | Bernstein | Underperform |
| 2022-10-26 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2022-06-08 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2022-03-22 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-12-22 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-12-20 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2021-12-07 | Iniziato | Wells Fargo | Underweight |
| 2021-11-18 | Iniziato | Barclays | Equal Weight |
| 2021-11-08 | Downgrade | CIBC | Neutral → Sector Underperform |
| 2021-11-08 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2021-11-08 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-10-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-08-12 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-06-02 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2021-05-25 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-24 | Downgrade | Jefferies | Hold → Underperform |
| 2021-02-10 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2021-02-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-02-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-09-04 | Aggiornamento | CFRA | Buy → Strong Buy |
| 2020-06-01 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2020-06-01 | Downgrade | Bryan Garnier | Neutral → Sell |
| 2020-06-01 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-01 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-01 | Downgrade | Stifel | Buy → Sell |
| 2020-05-22 | Ripresa | BofA/Merrill | Buy |
| 2020-04-16 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-01-28 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2019-12-12 | Reiterato | Cantor Fitzgerald | Neutral |
| 2019-11-20 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-15 | Downgrade | Alliance Global Partners | Buy → Neutral |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-14 | Downgrade | Seaport Global Securities | Buy → Neutral |
| 2019-10-11 | Downgrade | Jefferies | Hold → Underperform |
| 2019-09-27 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-18 | Iniziato | Oppenheimer | Perform |
| 2019-08-26 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Canopy Growth Corporation Borsa (CGC) Ultime notizie
Should Canopy Growth stock be in your portfolio post Q3 earnings? - MSN
Should Canopy Growth Stock Be in Your Portfolio Post Q3 Earnings? - The Globe and Mail
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Canopy Growth Corporation Postpones Annual General and Special Shareholders Meeting Due to Insufficient Quorum - Intellectia AI
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders - Newswire Canada
Canopy Growth Reports Substantial Loss Reduction in Q3 Earnings - AD HOC NEWS
(WEED) Proactive Strategies (WEED:CA) - Stock Traders Daily
Canopy Growth Reports Mixed Quarterly Results and Strategic Acquisition - AD HOC NEWS
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Canopy Growth’s Mixed Quarter: Losses Narrow but Earnings Miss - AD HOC NEWS
Canopy Growth Reports Sharply Narrowed Losses in Q3 - AD HOC NEWS
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Canopy Growth’s Narrowing Losses Met With Analyst Skepticism - AD HOC NEWS
Canopy Growth (TSX:WEED) Valuation Check After Narrowed Losses And New Shelf Registration - Yahoo Finance
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Canopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus - MSN
Is It Time to Dump Your Shares of Canopy Growth Corp? - Yahoo Finance
Canopy Growth Corporation (NASDAQ:CGC) Q3 2026 Earnings Call Transcript - Insider Monkey
When (WEED) Moves Investors should Listen (WEED:CA) - Stock Traders Daily
Wall Street Zen Downgrades Canopy Growth (NASDAQ:CGC) to Sell - MarketBeat
Canopy Growth Narrows Losses Amid Strategic Restructuring - AD HOC NEWS
Canopy Growth Q3 2026 Earnings Call Transcript - MarketBeat
Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares - GuruFocus
Canopy Growth Q3 Earnings Call Highlights - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in ... By GuruFocus - Investing.com Canada
Canopy Growth (NASDAQ:CGC) Posts Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Canopy Growth Corp (TSX:WEED) Shifts Focus While Tracking TSX Smallcap Index Today - Kalkine Media
Canopy’s domestic sales increase in Q3 2026 while international sales decline - StratCann
Earnings call transcript: Canopy Growth Q3 2026 misses EPS, beats revenue - Investing.com
WEED: Revenue growth, cost savings, and MTL acquisition position for positive EBITDA in 2027 - TradingView
WEED: Q3 delivered revenue growth, improved margins, and a stronger balance sheet, with MTL acquisition ahead - TradingView
Canopy Growth Reports Narrowed Losses Amid Strategic Overhaul - AD HOC NEWS
Stocks in play: Canopy Growth Corporation - Barchart.com
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Canopy Growth posts mixed Q3 results, narrower loss amid ongoing cost cuts - Proactive financial news
Canopy Growth reports Q3 EPS (C$0.18) vs. (C$1.11) last year - TipRanks
Canopy Growth (CGC) Q3 FY2026 earnings: loss narrows by 49% - grafa.com
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise - TipRanks
Canopy Growth Q3 Net Loss Narrows - marketscreener.com
Canopy Growth posts Q3 FY26 results (CGC:NASDAQ) - Seeking Alpha
Canopy Growth Brief: Citing $371M in Cash and Cash Equivalents With a Net Cash Position of $146M at Dec. 31, 2025 - marketscreener.com
Canopy Growth Brief: Basic and Diluted Loss Per Share $0.18 - marketscreener.com
Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results - The Globe and Mail
WEED: Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold - TradingView
Canopy Growth Q3 revenue beats estimates driven by insured patients, larger orders - TradingView
Canopy Growth (CGC) Misses Q3 EPS by 14c - StreetInsider
Canopy Growth Corp SEC 10-Q Report - TradingView
Canopy Growth Corporation Azioni (CGC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):